Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Biogen Inc. buy Traumtanz

Start price
€194.35
27.04.24 / 50%
Target price
€200.00
27.04.25
Performance (%)
4.19%
Price
€202.50
10:36
Summary
This prediction is currently active. With a performance of 4.19%, the BUY prediction by Traumtanz for Biogen Inc. is trending in the right direction. This prediction currently runs until 27.04.25. The prediction end date can be changed by Traumtanz at any time. Traumtanz has 50% into this prediction
Performance without dividends (%)
Name 1w
Biogen Inc. 1.092%
iShares Core DAX® 2.831%
iShares Nasdaq 100 2.918%
iShares Nikkei 225® 2.007%
iShares S&P 500 2.257%

According to Traumtanz what are the pros and cons of Biogen Inc. for the foreseeable future?

Pros
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Medium risks for its business
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Fair valuation
ROE higher than 10% per year
Good culture
Some uniques
Top 10 in its market
Small cyclical dependencies
Known brand
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High dividend yield expected
positive Cash Flow expected
Valuable balance sheet
Normal challenges to pay loans and raise capital
Capable Management
Cons

Comments by Traumtanz for this prediction

In the thread Biogen Inc. diskutieren
Prediction Buy
Perf. (%) 4.19%
Target price 200.000
Change
Ends at

Buy mit Kursziel 200,0

Stopped prediction by Traumtanz for Biogen Inc.

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€262.20
03.07.23
€270.00
03.07.24
-25.88%
27.04.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio